Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$452.30
+0.34%
Mkt Cap $112.92B
Analyst Ratings
Buy
25
Hold
4
Sell
0
Price Target (85 analysts)
$549.73
Range $441.00 – $607.00
Implied Upside
+21.5%
Consensus $549.73 vs current $452.30